Suki has secured $90 million in Series E funding to accelerate its growth and expand its artificial intelligence capabilities. The funding round included new investors Healthier Capital, Crosslink Capital and Hercules Capital, as well as existing backers Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures.
Suki CEO and founder Punit Soni told Fierce Healthcare that the company plans to invest the new capital in three areas: advancing its AI technology, expanding its commercial organization and scaling its partner ecosystem.
READ: AI startup Papaya joins Y Combinator Fall 2026 batch (September 16, 2026)
“The bigger picture is that healthcare AI is moving beyond documentation,” Soni said. “Health systems want AI that can do more than capture a conversation. They want intelligence that can support clinical decisions, improve financial performance, and streamline operations.”
Soni said the industry “doesn’t need another collection of disconnected AI tools.”
“Health systems are already dealing with too many point solutions that don’t talk to each other, creating more complexity instead of less,” Soni said. “We believe the answer is a connected, intelligent operating system for healthcare, one that brings AI together across clinical, financial, and operational workflows rather than keeping it confined to individual applications.”
“The goal isn’t to build every capability ourselves. It’s to bring together the best of healthcare AI in a way that works seamlessly for clinicians and health systems. Our vision is much bigger than ambient documentation or any single AI application. We’re building toward a future where intelligence connects the entire healthcare experience,” Soni added.
According to company executives, Suki has raised more than $250 million to date. Patient encounters involving its AI tools grew 190% year over year in 2026, the executives said. The company now works with more than 250 health care organizations and over 30 technology partners that integrate its AI into their platforms.
“What makes Suki particularly compelling is its dual approach: delivering AI directly to clinicians through its own application, Suki for Clinicians, while also powering AI capabilities within the platforms and technologies healthcare organizations already use,” Healthier Capital partner Aman Mahajan said. “Combined with its sophisticated AI, deep clinical integrations, and demonstrated outcomes, this approach gives Suki a unique opportunity to scale intelligence across healthcare. We believe Suki can become the foundational infrastructure for how healthcare operates in the AI era.”
Read: Oracle may cut more jobs as AI data center spending puts pressure on cash (September 12, 2026)
Suki plans to use the funding to develop AI agents capable of handling tasks such as referrals, prior authorizations and follow-up scheduling, according to a company announcement on LinkedIn.
The funding announcement follows the launch of a new Suki for Clinicians feature that allows clinicians to ask complex clinical questions through Wolters Kluwer’s UpToDate Expert AI API directly within the app.
